germany
germany · page 6
- US & Canada
The New Federal Government Drugs Commissioner Remains Vague on the Cannabis Issue
With the appointment of Prof. Dr. Hendrik Streeck as the new Federal Government Commissioner for Drugs, Burkhard Blienert had to say goodbye to this post, seeing a supporter of legalisation replaced by a scientist who became well-known during the coronavirus pandemic take the helm in drug policy in Germany.
- Uncategorized
Court Ruling Against German Online Cannabis Clinic Signals Looming Crackdown
Germany tightens control on online cannabis prescriptions. Court ruling bans advertising, while Health Minister calls for stricter access to medical cannabis via online platforms.
- Uncategorized
‘It’s Disneyland for Cannabis’: Mary Jane Berlin Founder on Taking the Grassroots Festival to New Heights
Ahead of Mary Jane Berlin, which returns later this month as part of European Cannabis Week, CEO Duc Anh Dang, spoke to Business of Cannabis about taking the festival to the next level and learning lessons along the way.
- Data & Analysis
Germany’s Green Rush: Medical Cannabis Imports Continue Record Growth, As Political Pushback Grows in Tandem
German medical cannabis imports have continued their meteoric rise in the wake of the passage of its Cannabis Act (CanG), rising a further 15% on Q4, 2024 in the first quarter of 2025, totalling 37,223 kg.
- Uncategorized
What Can the UK Learn From Germany’s Booming Medical Cannabis Market?
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
- Uncategorized
European Cannabis Businesses Get Off to Flying Start in 2025
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
- Uncategorized
Public Health, Pilot Projects and Politics: Mapping Adult-Use Cannabis in Europe
We have delved into some of the key data and insights set to be integrated into the new site, providing a taste of what readers can expect. For further exclusive analysis into the European cannabis market, pre-orders for data packages are available now.
- Adult-Use
German Cannabis Law Remains Uncertain, Malta Imposes Controversial Changes, Dutch Cannabis Experiment Progresses, & More from Czech Republic
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
- Markets & Stocks
Argent Bio’s Stock Flies on German Approval, Jazz Hit by Tariff Barrage, & Kanabo Cautions ‘Financial Uncertainty’
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its stock jump over 40% in the wake of two major announcements.
- Data & Analysis
What Impact Has Partial Cannabis Legalisation Had on Germany One Year On?
Since April 01 2024, hundreds of millions of Euros have been invested into the German medical cannabis sector, hundreds of thousands of criminal proceedings have been avoided, and millions of citizens have enjoyed free and legal access to cannabis for the first time.
- Medical
German Cannabis Imports Double in 2024, but Political Pressure Builds On Flourishing Medical Market
Germany imported a record amount of cannabis in the final quarter of 2024, seeing imports more than double for the full year as the acceleration of its thriving medical cannabis market shows no signs of slowing down.
